WASHINGTON, D.C. January 5, 2005) -- Advance media registration is now open for the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2005, scheduled February 23-24 at the Waldorf=Astoria in New York City. Now in its seventh year, the event will provide an opportunity for key industry players to examine investment opportunities and issues affecting the biotechnology industry.
This year’s program will feature focused discussions and corporate presentations by over 200 companies from the U.S., Europe, and Canada. Experts in clinical, financial, and regulatory issues will present their views on the most promising developments in medical biotechnology as well as on various diseases and medical conditions including hepatitis, lupus, cancer, HIV, diabetes, and eye disorders. The event will also feature one-on-one meetings arranged for investors with corporate management.
Registration is complimentary for credentialed news media. Advance registration is available until February 14, 2005. To register and to view the full conference program, please visit www.bio.org. Only reporters and editors working full time for print or broadcast news organizations may register onsite with valid media credentials.
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.